Protective effect of Egyptian propolis against rabbit pasteurellosis.
The present study was conducted to study the protective effect of ethanolic extract of propolis given subcutaneously (S/C) either alone or in combination with inactivated formalized Pasteurella multocida (P. multocida) vaccine in rabbits challenged with virulent P. multocida strain. Twenty-eight New-Zealand rabbits, 6-8 weeks old and not vaccinated against pasteurellosis, were randomly divided into four equal groups. Group (1) was kept as nonvaccinated control. Group (2) was injected S/C with propolis. Group (3) was vaccinated (S/C) with P. multocida vaccine only. Group (4) was injected with vaccine mixed with propolis as adjuvant. Groups (2, 3, and 4) received the same doses of propolis and vaccine after 4 weeks as a booster dose. The experiment continued for six weeks during which clinical signs, body weight, and mortality rate were recorded. Blood samples were collected every 2 weeks of treatment for evaluating the erythrogram and biochemical parameters. At the end of six weeks, all groups were subjected to challenge with a virulent strain of P. multocida. Two weeks later, tissue specimens were collected from different organs for histopathological investigation. Results showed that before challenge all rabbits of different groups were apparently healthy and had good appetite. After challenge, control group (1) showed acute form of the disease, 100% mortality rate, and severe histopathological changes. Rabbits of groups (2 and 3) showed less severe clinical signs, mortality rate, and histopathological changes than control. Rabbits of group (4) were apparently healthy with normal histological picture. In conclusion, an ethanolic extract of propolis injected alone or combined with formalized inactivated P. multocida vaccine improved general health conditions, liver and kidney functions in addition to reduction of the severity of adverse clinical signs, mortality rates, and histopathological changes associated with challenge of rabbits with P. multocida strain.
Department of Parasitology and Animal Diseases, National Research Center, El-Behouse Street, Dokki, P.O. Box 12622, Giza, Egypt.
Somia A
SA
Nassar
Amira H
AH
Mohamed
Hamdy
H
Soufy
Soad M
SM
Nasr
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D004534:Egypt; D004912:Erythrocytes / Q000187:drug effects; D007150:Immunohistochemistry; D008297:Male; D009928:Organ Specificity / Q000187:drug effects; D010326:Pasteurella Infections / Q000097:blood / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D011429:Propolis / Q000494:pharmacology / Q000627:therapeutic use; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D016019:Survival Analysis; D014508:Urea / Q000097:blood
D020011:Protective Agents; D014508:Urea; D011429:Propolis; D003404:Creatinine